Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Sales | 12,902,000 | 10,425,000 | 8,619,000 | 8,704,000 | 8,479,000 |
Cost of Goods | 5,050,000 | 3,711,000 | 1,942,000 | 2,006,000 | 1,920,000 |
Gross Profit | 7,852,000 | 6,714,000 | 6,677,000 | 6,698,000 | 6,559,000 |
Operating Expenses | 4,597,000 | 5,962,000 | 3,074,000 | 2,742,000 | 3,942,000 |
Operating Income | 3,255,000 | 752,000 | 3,603,000 | 3,956,000 | 2,617,000 |
Interest Expense | 620,000 | 614,000 | 428,000 | 455,000 | 420,000 |
Other Income | -135,000 | -831,000 | -77,000 | -427,000 | -196,000 |
Pre-tax Income | 2,500,000 | -693,000 | 3,098,000 | 3,074,000 | 2,001,000 |
Income Tax | 187,000 | 46,000 | 88,000 | 273,000 | 117,000 |
Net Income Continuous | 2,313,000 | -739,000 | 3,010,000 | 2,801,000 | 1,884,000 |
Minority Interests | 5,000 | -1,000 | N/A | N/A | N/A |
Net Income | $2,308,000 | $-738,000 | $3,010,000 | $2,801,000 | $1,884,000 |
EPS Basic Total Ops | 1.30 | -0.46 | 2.02 | 1.89 | 1.27 |
EPS Basic Continuous Ops | 1.31 | -0.45 | 2.03 | 1.89 | 1.27 |
EPS Diluted Total Ops | 1.29 | -0.46 | 2.02 | 1.88 | 1.26 |
EPS Diluted Continuous Ops | 1.30 | -0.45 | 2.03 | 1.89 | 1.27 |
EBITDA(a) | $5,547,000 | $2,307,000 | $4,162,000 | $4,465,000 | $3,120,000 |